BJU Int

1. LAZAROVICH A, Kristof TW, Steadman S, Dahmen AS, et al
   Prostate cancer and solid organ transplantation: patient management and outcomes.
   BJU Int. 2024 Oct 9. doi: 10.1111/bju.16558.
   

   >> Share

   
   

   
   BMC Cancer

2. ABIKAR A, Mustafa MMS, Athalye RR, Nadig N, et al
   Comparative transcriptome of normal and cancer-associated fibroblasts.
   BMC Cancer. 2024;24:1231.
   

   >> Share

   
   
3. LI X, Li Y, Zhang L, Long H, et al
   Single-cell sequencing analysis revealed that NEAT1 was a potential biomarker and therapeutic target of prostate cancer.
   BMC Cancer. 2024;24:1242.
   

   >> Share

   
   
4. SONG J, Sun X, Wang T, Li C, et al
   Circulating levels of cytokines and risk of urologic cancers: a two-sample Mendelian randomization study.
   BMC Cancer. 2024;24:1261.
   

   >> Share

   
   

   
   BMC Urol

5. VON AHLEN C, Geissler A, Vogel J
   Comparison of the effectiveness of open, laparoscopic, and robotic-assisted radical prostatectomies based on complication rates: a retrospective observational study with administrative data from Switzerland.
   BMC Urol. 2024;24:215.
   

   >> Share

   
   

   
   Cancer

6. CIRULLI GO, Davis M, Stephens A, Chiarelli G, et al
   Midlife baseline prostate-specific antigen, velocity, and doubling time association with lethal prostate cancer and mortality.
   Cancer. 2024 Oct 8. doi: 10.1002/cncr.35563.
   

   >> Share

   
   

   
   Cancer Imaging

7. BURGARD C, Rosar F, Larsen E, Khreish F, et al
   Outstanding increase in tumor-to-background ratio over time allows tumor localization by [(89)Zr]Zr-PSMA-617 PET/CT in early biochemical recurrence of prostate cancer.
   Cancer Imaging. 2024;24:132.
   

   >> Share

   
   

   
   Cancer Res

8. ZHANG L, Troccoli CI, Mateo-Victoriano B, Misiara Lincheta L, et al
   Stimulating Soluble Guanylyl Cyclase with the Clinical Agonist Riociguat Restrains the Development and Progression of Castration-Resistant Prostate Cancer.
   Cancer Res. 2024 Oct 10. doi: 10.1158/0008-5472.CAN-24-0133.
   

   >> Share

   
   

   
   Eur Urol

9. GILLESSEN S, Turco F, Davis ID, Efstathiou JA, et al
   Management of Patients with Advanced Prostate Cancer. Report from the 2024 Advanced Prostate Cancer Consensus Conference (APCCC).
   Eur Urol. 2024 Oct 10:S0302-2838(24)02610-1. doi: 10.1016/j.eururo.2024.
   

   >> Share

   
   
10. BAKHT MK, Beltran H
    Aiming High: Prostate-specific Membrane Antigen Expression in Treatment-naive Prostate Cancer.
    Eur Urol. 2024 Oct 10:S0302-2838(24)02637-X. doi: 10.1016/j.eururo.2024.
    

    >> Share

    
    
11. ONG WL, Loblaw A
    Radiotherapy for Unfavorable-risk Prostate Cancer: Biologic Dose Escalation, Fewer Fractions, or Both?
    Eur Urol. 2024 Oct 9:S0302-2838(24)02636-8. doi: 10.1016/j.eururo.2024.
    

    >> Share

    
    

    
    Int J Cancer

12. GRENVILLE ZS, Noor U, Rinaldi S, Gunter MJ, et al
    Perturbations in the blood metabolome up to a decade before prostate cancer diagnosis in 4387 matched case-control sets from the European Prospective Investigation into Cancer and Nutrition.
    Int J Cancer. 2024 Oct 8. doi: 10.1002/ijc.35208.
    

    >> Share

    
    

    
    Int J Urol

13. SATO M, Osawa T, Nishioka K, Miyazaki T, et al
    Decision regret after curative treatment and its association with the decision-making process and quality of life for prostate cancer patients.
    Int J Urol. 2024 Oct 9. doi: 10.1111/iju.15602.
    

    >> Share

    
    

    
    J Natl Cancer Inst

14. LIU S, Rivero SL, Zhang B, Shen K, et al
    BATF-dependent Th17 cells act through the IL-23R pathway to promote prostate adenocarcinoma initiation and progression.
    J Natl Cancer Inst. 2024;116:1598-1611.
    

    >> Share

    
    
15. KATKI HA, Prorok PC, Castle PE, Minasian LM, et al
    Increasing power in screening trials by testing control-arm specimens: application to multicancer detection screening.
    J Natl Cancer Inst. 2024;116:1675-1682.
    

    >> Share

    
    

    
    J Urol

16. NABI R, Zahid T, Farooqi HA
    Letter: Radical Prostatectomy Without Prior Biopsy in Selected Patients Evaluated by (18)F-Labeled Prostate-Specific Membrane Antigen-Ligand Positron Emission Tomography/Computed Tomography and Multiparameter Magnetic Resonance Imaging: A Single-Cente
    J Urol. 2024;212:762-763.
    

    >> Share

    
    
17. FAKUNLE MO, Cowan JE, Washington SL 3rd, Shinohara K, et al
    Targeted Biopsy is Sufficient for Men on Active Surveillance for Early-Stage Prostate Cancer.
    J Urol. 2024 Oct 9:101097JU0000000000004265. doi: 10.1097/JU.0000000000004265.
    

    >> Share

    
    

    
    N Engl J Med

18. HOLMBERG L, Garmo H, Andersson SO, Andren O, et al
    Radical Prostatectomy or Watchful Waiting in Early Prostate Cancer.
    N Engl J Med. 2024;391:1362-1364.
    

    >> Share

    
    

    
    Nat Rev Urol

19. MASONE MC
    Intralesional heterogeneity on PSMA PET-CT predicts mCRPC outcomes.
    Nat Rev Urol. 2024;21:577.
    

    >> Share

    
    
20. MASONE MC
    Cell death score predicts prostate cancer metastasis and immunotherapy response.
    Nat Rev Urol. 2024 Oct 10. doi: 10.1038/s41585-024-00954.
    

    >> Share

    
    

    
    Oncogene

21. XIONG X, Zhang S, Zhu W, Du J, et al
    Androgen-ablative therapies inducing CXCL8 regulates mTORC1/SREBP2-dependent cholesterol biosynthesis to support progression of androgen receptor negative prostate cancer cells.
    Oncogene. 2024 Oct 5. doi: 10.1038/s41388-024-03181.
    

    >> Share

    
    

    
    Oncology

22. NOVYSEDLAK R, Guney M, Al Khouri M, Bartolini R, et al
    The Immune Microenvironment in Prostate Cancer: A Comprehensive Review.
    Oncology. 2024 Oct 9:1-37. doi: 10.1159/000541881.
    

    >> Share

    
    

    
    Prostate

23. FALKENBACH F, Schmalhofer ML, Tian Z, Mazzucato G, et al
    Size and SUV(max) define the contribution of nodal metastases to PSA in oligorecurrent prostate cancer.
    Prostate. 2024 Oct 9. doi: 10.1002/pros.24806.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share